カテゴリ： 世界, 医療/バイオ, QYResearch

顔面リポジストロフィー治療剤の世界市場2023年：皮膚フィラー、手術

■ 英語タイトル：Global Facial Lipodystrophy Treatment Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7464）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7464
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：87
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[顔面リポジストロフィー治療剤の世界市場2023年：皮膚フィラー、手術]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は顔面リポジストロフィー治療剤のグローバル市場について調査・分析し、世界の顔面リポジストロフィー治療剤市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（皮膚フィラー、手術）、用途別セグメント分析（病院、専門クリニック、美容整形センター）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Galderma Laboratories、Merz GmbH & Co. KGaA、Sanofi SA、Zimmer Biomet、Anika Therapeutics、Ferring BV、Bioventusなどが含まれています。顔面リポジストロフィー治療剤のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、顔面リポジストロフィー治療剤市場規模を算出する際に考慮しました。

・顔面リポジストロフィー治療剤市場の概要
- 顔面リポジストロフィー治療剤の種類別セグメント
- 世界の顔面リポジストロフィー治療剤市場規模：タイプ別分析（皮膚フィラー、手術）
- 顔面リポジストロフィー治療剤の用途別セグメント
- 世界の顔面リポジストロフィー治療剤市場規模：用途別分析（病院、専門クリニック、美容整形センター）
- 世界の顔面リポジストロフィー治療剤市場規模予測（2018年-2029年）

・顔面リポジストロフィー治療剤市場の成長トレンド
- 顔面リポジストロフィー治療剤の地域別市場規模（2018年-2029年）
- 顔面リポジストロフィー治療剤市場ダイナミクス
- 顔面リポジストロフィー治療剤の業界動向
- 顔面リポジストロフィー治療剤市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：皮膚フィラー、手術
- 世界の顔面リポジストロフィー治療剤のタイプ別市場規模（2018年-2023年）
- 世界の顔面リポジストロフィー治療剤のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、専門クリニック、美容整形センター
- 世界の顔面リポジストロフィー治療剤の用途別市場規模（2018年-2023年）
- 世界の顔面リポジストロフィー治療剤の用途別市場規模（2024年-2029年）

・顔面リポジストロフィー治療剤の地域別市場規模
- 北米の顔面リポジストロフィー治療剤市場規模（2018年-2029年）
- 米国の顔面リポジストロフィー治療剤市場規模（2018年-2029年）
- ヨーロッパの顔面リポジストロフィー治療剤市場規模（2018年-2029年）
- アジア太平洋の顔面リポジストロフィー治療剤市場規模（2018年-2029年）
- 中国の顔面リポジストロフィー治療剤市場規模（2018年-2029年）
- 日本の顔面リポジストロフィー治療剤市場規模（2018年-2029年）
- 韓国の顔面リポジストロフィー治療剤市場規模（2018年-2029年）
- インドの顔面リポジストロフィー治療剤市場規模（2018年-2029年）
- オーストラリアの顔面リポジストロフィー治療剤市場規模（2018年-2029年）
- 中南米の顔面リポジストロフィー治療剤市場規模（2018年-2029年）
- 中東・アフリカの顔面リポジストロフィー治療剤市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Galderma Laboratories、Merz GmbH & Co. KGaA、Sanofi SA、Zimmer Biomet、Anika Therapeutics、Ferring BV、Bioventus

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Facial Lipodystrophy Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Facial Lipodystrophy Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Facial Lipodystrophy Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Facial Lipodystrophy Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Facial Lipodystrophy Treatment include Galderma Laboratories, Merz GmbH & Co. KGaA, Sanofi SA, Zimmer Biomet, Anika Therapeutics, Ferring BV and Bioventus, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Facial Lipodystrophy Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Facial Lipodystrophy Treatment.
The Facial Lipodystrophy Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Facial Lipodystrophy Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Facial Lipodystrophy Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Galderma Laboratories
Merz GmbH & Co. KGaA
Sanofi SA
Zimmer Biomet
Anika Therapeutics
Ferring BV
Bioventus
Segment by Type
Dermal Filler
Surgery
Segment by Application
Hospital
Specialty Clinics
Plastic Surgery Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Facial Lipodystrophy Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Facial Lipodystrophy Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Dermal Filler
1.2.3 Surgery
1.3 Market by Application
1.3.1 Global Facial Lipodystrophy Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Specialty Clinics
1.3.4 Plastic Surgery Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Facial Lipodystrophy Treatment Market Perspective (2018-2029)
2.2 Facial Lipodystrophy Treatment Growth Trends by Region
2.2.1 Global Facial Lipodystrophy Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Facial Lipodystrophy Treatment Historic Market Size by Region (2018-2023)
2.2.3 Facial Lipodystrophy Treatment Forecasted Market Size by Region (2024-2029)
2.3 Facial Lipodystrophy Treatment Market Dynamics
2.3.1 Facial Lipodystrophy Treatment Industry Trends
2.3.2 Facial Lipodystrophy Treatment Market Drivers
2.3.3 Facial Lipodystrophy Treatment Market Challenges
2.3.4 Facial Lipodystrophy Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Facial Lipodystrophy Treatment Players by Revenue
3.1.1 Global Top Facial Lipodystrophy Treatment Players by Revenue (2018-2023)
3.1.2 Global Facial Lipodystrophy Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Facial Lipodystrophy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Facial Lipodystrophy Treatment Revenue
3.4 Global Facial Lipodystrophy Treatment Market Concentration Ratio
3.4.1 Global Facial Lipodystrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Facial Lipodystrophy Treatment Revenue in 2022
3.5 Facial Lipodystrophy Treatment Key Players Head office and Area Served
3.6 Key Players Facial Lipodystrophy Treatment Product Solution and Service
3.7 Date of Enter into Facial Lipodystrophy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Facial Lipodystrophy Treatment Breakdown Data by Type
4.1 Global Facial Lipodystrophy Treatment Historic Market Size by Type (2018-2023)
4.2 Global Facial Lipodystrophy Treatment Forecasted Market Size by Type (2024-2029)
5 Facial Lipodystrophy Treatment Breakdown Data by Application
5.1 Global Facial Lipodystrophy Treatment Historic Market Size by Application (2018-2023)
5.2 Global Facial Lipodystrophy Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Facial Lipodystrophy Treatment Market Size (2018-2029)
6.2 North America Facial Lipodystrophy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Facial Lipodystrophy Treatment Market Size by Country (2018-2023)
6.4 North America Facial Lipodystrophy Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Facial Lipodystrophy Treatment Market Size (2018-2029)
7.2 Europe Facial Lipodystrophy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Facial Lipodystrophy Treatment Market Size by Country (2018-2023)
7.4 Europe Facial Lipodystrophy Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Facial Lipodystrophy Treatment Market Size (2018-2029)
8.2 Asia-Pacific Facial Lipodystrophy Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Facial Lipodystrophy Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Facial Lipodystrophy Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Facial Lipodystrophy Treatment Market Size (2018-2029)
9.2 Latin America Facial Lipodystrophy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Facial Lipodystrophy Treatment Market Size by Country (2018-2023)
9.4 Latin America Facial Lipodystrophy Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Facial Lipodystrophy Treatment Market Size (2018-2029)
10.2 Middle East & Africa Facial Lipodystrophy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Facial Lipodystrophy Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Facial Lipodystrophy Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Galderma Laboratories
11.1.1 Galderma Laboratories Company Detail
11.1.2 Galderma Laboratories Business Overview
11.1.3 Galderma Laboratories Facial Lipodystrophy Treatment Introduction
11.1.4 Galderma Laboratories Revenue in Facial Lipodystrophy Treatment Business (2018-2023)
11.1.5 Galderma Laboratories Recent Development
11.2 Merz GmbH & Co. KGaA
11.2.1 Merz GmbH & Co. KGaA Company Detail
11.2.2 Merz GmbH & Co. KGaA Business Overview
11.2.3 Merz GmbH & Co. KGaA Facial Lipodystrophy Treatment Introduction
11.2.4 Merz GmbH & Co. KGaA Revenue in Facial Lipodystrophy Treatment Business (2018-2023)
11.2.5 Merz GmbH & Co. KGaA Recent Development
11.3 Sanofi SA
11.3.1 Sanofi SA Company Detail
11.3.2 Sanofi SA Business Overview
11.3.3 Sanofi SA Facial Lipodystrophy Treatment Introduction
11.3.4 Sanofi SA Revenue in Facial Lipodystrophy Treatment Business (2018-2023)
11.3.5 Sanofi SA Recent Development
11.4 Zimmer Biomet
11.4.1 Zimmer Biomet Company Detail
11.4.2 Zimmer Biomet Business Overview
11.4.3 Zimmer Biomet Facial Lipodystrophy Treatment Introduction
11.4.4 Zimmer Biomet Revenue in Facial Lipodystrophy Treatment Business (2018-2023)
11.4.5 Zimmer Biomet Recent Development
11.5 Anika Therapeutics
11.5.1 Anika Therapeutics Company Detail
11.5.2 Anika Therapeutics Business Overview
11.5.3 Anika Therapeutics Facial Lipodystrophy Treatment Introduction
11.5.4 Anika Therapeutics Revenue in Facial Lipodystrophy Treatment Business (2018-2023)
11.5.5 Anika Therapeutics Recent Development
11.6 Ferring BV
11.6.1 Ferring BV Company Detail
11.6.2 Ferring BV Business Overview
11.6.3 Ferring BV Facial Lipodystrophy Treatment Introduction
11.6.4 Ferring BV Revenue in Facial Lipodystrophy Treatment Business (2018-2023)
11.6.5 Ferring BV Recent Development
11.7 Bioventus
11.7.1 Bioventus Company Detail
11.7.2 Bioventus Business Overview
11.7.3 Bioventus Facial Lipodystrophy Treatment Introduction
11.7.4 Bioventus Revenue in Facial Lipodystrophy Treatment Business (2018-2023)
11.7.5 Bioventus Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Facial Lipodystrophy Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Dermal Filler
Table 3. Key Players of Surgery
Table 4. Global Facial Lipodystrophy Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Facial Lipodystrophy Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Facial Lipodystrophy Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Facial Lipodystrophy Treatment Market Share by Region (2018-2023)
Table 8. Global Facial Lipodystrophy Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Facial Lipodystrophy Treatment Market Share by Region (2024-2029)
Table 10. Facial Lipodystrophy Treatment Market Trends
Table 11. Facial Lipodystrophy Treatment Market Drivers
Table 12. Facial Lipodystrophy Treatment Market Challenges
Table 13. Facial Lipodystrophy Treatment Market Restraints
Table 14. Global Facial Lipodystrophy Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Facial Lipodystrophy Treatment Market Share by Players (2018-2023)
Table 16. Global Top Facial Lipodystrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Facial Lipodystrophy Treatment as of 2022)
Table 17. Ranking of Global Top Facial Lipodystrophy Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Facial Lipodystrophy Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Facial Lipodystrophy Treatment Product Solution and Service
Table 21. Date of Enter into Facial Lipodystrophy Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Facial Lipodystrophy Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Facial Lipodystrophy Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Facial Lipodystrophy Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Facial Lipodystrophy Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Facial Lipodystrophy Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Facial Lipodystrophy Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Facial Lipodystrophy Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Facial Lipodystrophy Treatment Revenue Market Share by Application (2024-2029)
Table 31. North America Facial Lipodystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Facial Lipodystrophy Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Facial Lipodystrophy Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Facial Lipodystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Facial Lipodystrophy Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Facial Lipodystrophy Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Facial Lipodystrophy Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Facial Lipodystrophy Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Facial Lipodystrophy Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Facial Lipodystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Facial Lipodystrophy Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Facial Lipodystrophy Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Facial Lipodystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Facial Lipodystrophy Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Facial Lipodystrophy Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Galderma Laboratories Company Detail
Table 47. Galderma Laboratories Business Overview
Table 48. Galderma Laboratories Facial Lipodystrophy Treatment Product
Table 49. Galderma Laboratories Revenue in Facial Lipodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 50. Galderma Laboratories Recent Development
Table 51. Merz GmbH & Co. KGaA Company Detail
Table 52. Merz GmbH & Co. KGaA Business Overview
Table 53. Merz GmbH & Co. KGaA Facial Lipodystrophy Treatment Product
Table 54. Merz GmbH & Co. KGaA Revenue in Facial Lipodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 55. Merz GmbH & Co. KGaA Recent Development
Table 56. Sanofi SA Company Detail
Table 57. Sanofi SA Business Overview
Table 58. Sanofi SA Facial Lipodystrophy Treatment Product
Table 59. Sanofi SA Revenue in Facial Lipodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 60. Sanofi SA Recent Development
Table 61. Zimmer Biomet Company Detail
Table 62. Zimmer Biomet Business Overview
Table 63. Zimmer Biomet Facial Lipodystrophy Treatment Product
Table 64. Zimmer Biomet Revenue in Facial Lipodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 65. Zimmer Biomet Recent Development
Table 66. Anika Therapeutics Company Detail
Table 67. Anika Therapeutics Business Overview
Table 68. Anika Therapeutics Facial Lipodystrophy Treatment Product
Table 69. Anika Therapeutics Revenue in Facial Lipodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 70. Anika Therapeutics Recent Development
Table 71. Ferring BV Company Detail
Table 72. Ferring BV Business Overview
Table 73. Ferring BV Facial Lipodystrophy Treatment Product
Table 74. Ferring BV Revenue in Facial Lipodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 75. Ferring BV Recent Development
Table 76. Bioventus Company Detail
Table 77. Bioventus Business Overview
Table 78. Bioventus Facial Lipodystrophy Treatment Product
Table 79. Bioventus Revenue in Facial Lipodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 80. Bioventus Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Facial Lipodystrophy Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Facial Lipodystrophy Treatment Market Share by Type: 2022 VS 2029
Figure 3. Dermal Filler Features
Figure 4. Surgery Features
Figure 5. Global Facial Lipodystrophy Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Facial Lipodystrophy Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Plastic Surgery Centers Case Studies
Figure 10. Facial Lipodystrophy Treatment Report Years Considered
Figure 11. Global Facial Lipodystrophy Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Facial Lipodystrophy Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Facial Lipodystrophy Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Facial Lipodystrophy Treatment Market Share by Players in 2022
Figure 15. Global Top Facial Lipodystrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Facial Lipodystrophy Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Facial Lipodystrophy Treatment Revenue in 2022
Figure 17. North America Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Facial Lipodystrophy Treatment Market Share by Country (2018-2029)
Figure 19. United States Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Facial Lipodystrophy Treatment Market Share by Country (2018-2029)
Figure 23. Germany Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Facial Lipodystrophy Treatment Market Share by Region (2018-2029)
Figure 31. China Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Facial Lipodystrophy Treatment Market Share by Country (2018-2029)
Figure 39. Mexico Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Facial Lipodystrophy Treatment Market Share by Country (2018-2029)
Figure 43. Turkey Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Facial Lipodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Galderma Laboratories Revenue Growth Rate in Facial Lipodystrophy Treatment Business (2018-2023)
Figure 46. Merz GmbH & Co. KGaA Revenue Growth Rate in Facial Lipodystrophy Treatment Business (2018-2023)
Figure 47. Sanofi SA Revenue Growth Rate in Facial Lipodystrophy Treatment Business (2018-2023)
Figure 48. Zimmer Biomet Revenue Growth Rate in Facial Lipodystrophy Treatment Business (2018-2023)
Figure 49. Anika Therapeutics Revenue Growth Rate in Facial Lipodystrophy Treatment Business (2018-2023)
Figure 50. Ferring BV Revenue Growth Rate in Facial Lipodystrophy Treatment Business (2018-2023)
Figure 51. Bioventus Revenue Growth Rate in Facial Lipodystrophy Treatment Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • エステティックにおける併用療法の世界市場2023年：BTx-A/皮膚フィラー、BTx-A/レーザー、レーザー/外用薬、レーザー/高周波、皮膚フィラー/外用薬、その他
  • シリコーン製フェイシャルインプラントのグローバル市場展望 2023年-2029年：アナトミカルフェイシャルインプラント、オーバルフェイシャルインプラント、ラウンドフェイシャルインプラント
  • ブルセラ症治療の世界市場2023年：経口式、注射式
  • 膵臓がん転移治療の世界市場2023年：化学療法、標的療法、その他
  • 関節内出血治療の世界市場2023年：手術治療、医療治療
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7464 )"顔面リポジストロフィー治療剤の世界市場2023年：皮膚フィラー、手術" (英文：Global Facial Lipodystrophy Treatment Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。